Swift Biosciences Launches Unique Dual Indexing Kits to Improve Multiplexed Next Generation Sequencing

Food and Healthcare Press Releases Monday April 9, 2018 09:50
ANN ARBOR, Michigan--9 Apr--PRNewswire/InfoQuest
  • New Accel-NGS Unique Dual Indexing Kits minimize read misassignments for higher quality results

Swift Biosciences today announced the launch of its Accel-NGS(R) Unique Dual Indexing Kits , which deliver the power and value of high-throughput multiplexed sequencing while improving the accuracy of low frequency variant calling, such as somatic mutations, in samples such as FFPE and cfDNA.

Multiplexed sequencing is a commonly used technique among clinical research, drug development and clinical services labs utilizing next-generation sequencing (NGS). The Accel-NGS Unique Dual Indexing Kits are an essential addition to NGS workflows, as current tools can suffer from demultiplexing problems caused by index read errors, PCR-induced chimerism associated with multiplexed hybridization capture workflows, and index hopping on patterned flow cells.

Swift's Accel-NGS Unique Dual Indexing Kits, developed in a set of 96 dual indices for both i7 and i5 positions, provide a more scalable and reliable workflow for a range of applications including:
  • Low-frequency somatic variant discovery
  • Formalin-fixed paraffin-embedded analysis
  • Microbial detection in human samples
  • Cell-free DNA analysis

"By directly addressing read misassignments we are providing a more accurate solution which could open up new applications, such as tumor mutation burden profiling," said Candia Brown, Swift's Vice President of Global Marketing.

Key features and benefits of the Accel-NGS Unique Dual Indexing Kits include:
  • Optimized across all Illumina sequencing instruments
  • Improves misassignment rates to less than 0.1 percent
  • Enables multiple applications including whole genome sequencing, whole exome and methylation analysis
  • Compatibility with Swift library prep kits including Accel-NGS 1S, Accel-NGS 2S, and Accel-NGS Methyl-Seq

"Swift's unique dual indices provide higher confidence in calling low frequency variants and maintains data quality as sequencing throughput and multiplexing capability continue to increase," said Laurie Kurihara, PhD, Swift's Vice President of Product Development.

The new indexing kits are specifically designed and compatible for any Illumina platform and are now commercially available.
About Swift Biosciences

Swift Biosciences is the NGS Library Prep company. Based in Ann Arbor, Michigan, the company develops novel library preparation solutions for emerging applications based on next-generation sequencing, including whole genome sequencing, targeted DNA sequencing, and epigenetic analysis. Swift Biosciences' products are designed to help customers analyze challenging biological samples faster, easier, and with greater sensitivity and accuracy, while being compatible with leading instrumentation. Swift Biosciences is the first company to offer library preparation solutions on all three major sequencing platforms, including Pacific Biosciences(R), Illumina(R) and Ion Torrent(TM).

The company opened its doors in February 2010, and its product development enables new applications in multiple industries, including agrigenomics, pharmaceutical, academic, biotechnology, and oncology research fields.

For more information, visit   SwiftBioSci.com and follow Swift Biosciences on Twitter (@SwiftBioSci).

Latest Press Release

Qatar Foundation Ushers in New Era of Healthcare With Official Inauguration of Sidra Medicine

Her Highness Sheikha Moza bint Nasser, Chairperson of Qatar Foundation (QF), today officially inaugurated Sidra Medicine - a brand new, world-leading women's and children's hospital in Qatar. The grand opening reflects the country's broader focus and...

Singapore National Eye Centre, Singapore Eye Research Institute And Johnson Johnson Vision Set Sights On Halting Global Myopia Epidemic

New US$26.35 Million Collaboration Seeks Prevention and Treatment Solutions to Address Rising Burden of Condition The Singapore National Eye Centre (SNEC), the Singapore Eye Research Institute (SERI) and Johnson & Johnson Vision today announced a...

TIENS Group Launches Global Expansion Into New Retail

Leading healthcare company, TIENS Group, has announced their global expansion into the new retail market with the opening of a new flagship TIENS Experience Store in China. Located in the TIENS International Health Industrial Park, the new store features...

Medicines We Can Trust Campaign Rallies Mekong Governments and Leaders to Improve Access to Quality Medicines

Cambodian Prime Minister Hun Sen and other leaders from the Greater Mekong Subregion joined hands as part of a global campaign to improve access to quality medicines. The announcement was made during the Phnom Penh Regional Conference on the fight...

SI Group Announces New Executive Leadership

SI Group, a leading global developer and manufacturer of performance additives, process solutions, pharmaceuticals and chemical intermediates, announced today the company's new executive leadership team. These changes follow the October 15, 2018...

Related Topics